What happens to your brain and body when you drop acid?
03:32 min
CLEAR ALL
Could psychedelics help us heal from trauma and mental illnesses? Researcher Rick Doblin has spent the past three decades investigating this question, and the results are promising.
1
Leading psychopharmacologist Roland Griffiths discloses the ways that psychedelic drugs can be used to create spiritually meaningful, personally transformative experiences for all patients, especially the terminally ill.
2
Psychedelics have an ancient and more recent history of medicinal-use. Administered in a supportive environment, with preparatory and integrative psychological care, psychedelic medicines are now being used to facilitate emotional breakthrough and renewed perspective.
REBUS and the Anarchic Brain: A Unified Model of the Brain Action of Psychedelics Robin Carhart-Harris moved to Imperial College London in 2008 after obtaining a PhD in Psychopharmacology from the University of Bristol and an MA in Psychoanalysis from Brunel University.
Dr. Robin Carhart-Harris, of the Neuropsychopharmacology Unit, Imperial College London, discusses research on Psilocybin and how psychedelics could be used in therapy to help with depression, addiction, and other problems of rigid thought patterns.
Pioneers in Research is a series of interviews conducted in 1998 that were recently digitized for the Psychoactive Substances Research Collection at the Purdue University Libraries Archives.
Dr. Stanislav Grof tells how he experienced LSD in the days it was legal and what insight he got from that work. Basel WPF March 2009
The Beckley Foundation Scientific Program conducts cutting edge research with LSD in human subjects, explores neurophysiological similarities between LSD and the mystical experience through observing modulations in the blood supply, brainwaves and a broad spectrum of cognitive changes.
Dr. James Fadiman is one of the godfathers of LSD research and pioneers into its applications for therapy and psychological exploration. Here he discusses micro-dosing, "sitters," and the changing legal landscape for psychedelic research.